|
Gonadotropin-releasing Hormone Analog Clinical Trials
2 actively recruiting trials across 2 locations
Also known as: GnRH Agonist, GnRH Analog, Gonadotropin-Releasing Hormone Agonist, Gonadotropin-Releasing Hormone Analogue, LH-RH Analogs, LH-RH agonist, LHRH Agonist, Luteinizing Hormone-Releasing Hormone Analog, luteinizing hormone-releasing hormone agonist
Scottsdale, Arizona1 trial
Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer
Mayo Clinic in Arizona
Phase 2
St Louis, Missouri1 trial
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
Siteman Cancer Center at Washington University
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.